Hsp60 response in experimental and human temporal lobe epilepsy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Gammazza, Antonella Marino ^a,b   Colangeli, Roberto ^c   Orban, Gergely ^a,b,c   Pierucci, Massimo ^b,c   Di Gennaro, Giancarlo ^d   Lo Bello, Margherita ^a   D'Aniello, Alfredo ^d   Bucchieri, Fabio ^a,b   Pomara, Cristoforo ^c,e   Valentino, Mario ^c   Muscat, Richard ^c   Benigno, Arcangelo ^a   Zummo, Giovanni ^a   De Macario, Everly Conway ^f,g   Cappello, Francesco ^a,b,h   Di Giovanni, Giuseppe ^b,c,i   Macario, Alberto J L ^b,f,g  

^a UNIVERSITY OF PALERMO   (Italy)

^b Euro Mediterranean Institute of Science and Technology   (Italy)

^c UNIVERSITY OF MALTA   (Malta)

^d IRCCS NEUROMED   (Italy)

^e UNIVERSITY OF FOGGIA   (Italy)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MARYLAND CENTER FOR ENVIRONMENTAL SCIENCE   (United States)

^h Institute Paolo Sotgiu for Research in Quantitative and Quantum Psychiatry and Cardiology University of Human Sciences and Technology (LUDES)   (Switzerland)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONIN 60;

ADULT; ANIMAL; BLOOD; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; RAT; TEMPORAL LOBE EPILEPSY; YOUNG ADULT;

ADULT; ANIMALS; CHAPERONIN 60; DENTATE GYRUS; EPILEPSY, TEMPORAL LOBE; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RATS; YOUNG ADULT;

EID: 84925356888     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09434     Document Type: Article

References (55)

1. Pitkänen, A. & Sutula, T. P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1, 173-181 (2002).
2. Sendrowski, K. & Sobaniec, W. Hippocampus, hippocampal sclerosis and epilepsy. Pharmacol. Rep. 65, 555-565 (2013).
3. Van Liefferinge, J., Massie, A., Portelli, J., Di Giovanni, G. & Smolders, I. Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy? Front. Cell. Neurosci. 7, 139 doi: 10.3389/fncel.2013.00139 (2013).
4. Wu, Y. T., Wu, S. B., Lee, W. Y. & Wie, Y. H. Mitochondrial respiratory dysfunction elicited oxidative stress and posttranslational protein modification in mitochondrial diseases. Ann. N. Y. Acad. Sci. 1201, 147-156 (2010).
5. Liu, X. Y. et al. Comparative proteomics and correlated signaling network of rat hippocampus in the pilocarpine model of temporal lobe epilepsy. Proteomics 8, 582-603 (2008).
6. Ravizza, T. et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 29, 142-160 (2008).
7. Arellano, J. I., Munoz, A., Ballesteros-Yanez, I., Sola, R. G. & De Felipe, J. Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus. Brain 127, 45-64 (2004).
8. Vezzani, A. & Friedman, A. Brain inflammation as a biomarker in epilepsy. Biomark Med. 5, 607-614 (2011).
9. Chang, C. C. et al. Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy. BMC Neurol. 12 doi: 10.1186/1471-2377-12-15 (2012).
10. Macario, A. J. L., Conway de Macario, E. & Cappello, F. The Chaperonopathies. Diseases with defective molecular chaperones [Springer (ed.)] (Dordrecht Heidelberg, New York, London, 2013).
11. Cappello, F. et al. Hsp60 chaperonopathies and chaperonotherapy: targets and agents. Expert Opin. Ther. Targets 18, 185-208 (2014).
12. Ohtsuka, K. & Suzuki, T. Roles of molecular chaperones in the nervous system. Brain Res. Bull. 53, 141-146 (2000).
13. Stetler, R. A. et al. Heat shock proteins: cellular and molecular mechanisms in the central nervous system. Prog. Neurobiol. 92, 184-211 (2010).
14. Czarnecka, A. M., Campanella, C., Zummo, G. & Cappello, F. Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics. Cancer Biol. Ther. 5, 714-720 (2006).
15. Bukau, B. & Horwich, A. L. The Hsp70 and Hsp60 chaperone machines. Cell 92, 351-366 (1998).
16. Parnas, A. et al. Identification of elements that dictate the specificity of mitochondrial Hsp60 for its co-chaperonin. PloS One 7, e50318 (2012).
17. D'Souza, S. M. & Brown, I. R. Constitutive expression of heat shock proteins Hsp90, Hsc70, Hsp70 and Hsp60 in neural and non-neural tissues of the rat during postnatal development. Cell Stress Chaperones 3, 188-199 (1998).
18. Merendino, A. M. et al.Hsp60 is actively secreted by human tumor cells. PLoS One 5, e9247 (2010).
19. Vilasi, S. et al . Human Hsp60 with its mitochondrial import signal occurs in solution as heptamers and tetradecamers remarkably stable over a wide range of concentrations. PLoS One 9, e97657 (2014).
20. Campanella, C. et al. The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLoS One 7, e42008 (2012).
21. Osterloh, A., Kalinke, U., Weiss, S., Fleischer, B. & Breloer, M. Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide. J. Biol. Chem. 282, 4669-4680 (2007).
22. Xie, J. et al. Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60-fused antigen into the MHC class I presentation pathway. J. Immunol. 185, 2306-2313 (2010).
23. Gazali, A. Conference scene: taking the heat out of chaperokine function. Immunotherapy 4, 773-775 (2012).
24. Campanella, C. et al. A comparative analysis of the products of GROEL-1 gene from Chlamydia trachomatis serovar D and the HSP60 var1 transcript from Homo sapiens suggests a possible autoimmune response. Int. J. Immunogenet. 36, 73-78 (2009).
25. Marino Gammazza, A. et al. Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasmamembrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis. Cell Stress Chaperones 19, 343-353 (2014).
26. Marino Gammazza, A. et al. The molecular anatomy of human Hsp60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential pathogenetic role of anti-chaperonin immunity in myasthenia gravis. Cell Mol. Neurobiol. 32, 943-994 (2012).
27. Stringer, J. L. & Lothman, E. W. Maximal dentate activation: a tool to screen compounds for activity against limbic seizures. Epilepsy Res. 5, 169-176 (1990).
28. Orban, G. et al. High dose of 8-OH-DPAT decreases maximal dentate gyrus activation and facilitates granular cell plasticity in vivo. Exp. Brain Res. 230, 441-451 (2013).
29. Orban, G. et al. Role(s) of the 5-HT2C Receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats. CNS Neurosci. Ther. 20, 651-661 (2014).
30. Stringer, J. L., Agarwal, K. S. & Dure, L. S. Is cell death necessary for hippocampal mossy fiber sprouting? Epilepsy Res. 27, 67-76 (1997).
31. Kim, Y. J., Kim, J. Y., Ko, A. R. & Kang, T. C. Reduction in heat shock protein 90 correlates to neuronal vulnerability in the rat piriform cortex following status epilepticus. Neuroscience 255, 265-277 (2013).
32. Rordorf, G., Koroshetz, W. J. & Bonventre, J. V. Heat shock protects cultured neurons from glutamate toxicity. Neuron. 7, 1043-1051 (1991).
33. Bidmon, H. J. et al. Heat shock protein-27 is upregulated in the temporal cortex of patients with epilepsy. Epilepsia 45, 1549-1559 (2004).
34. Yang, T., Hsu, C., Liao, W., & Chuang, J., S. Heat shock protein 70 expression in epilepsy suggests stress rather than protection. Acta neuropathol. 115, 219-230 (2008).
35. Kharlamov, E. A. et al. Alterations of GABA(A) and glutamate receptor subunits and heat shock protein in rat hippocampus following traumatic brain injury and in posttraumatic epilepsy. Epilepsy Res 95, 20-34 (2011).
36. Kandratavicius, L., Hallak, J. E., Carlotti, C. G., Assirati, J. A. & Leite, J. P. Hippocampal expression of heat shock proteins in mesial temporal lobe epilepsy with psychiatric comorbidities and their relation to seizure outcome. Epilepsia 55, 1834-1843 (2014).
37. Gass, P., Prior, P. & Kiessling, M. Correlation between seizure intensity and stress protein expression after limbic epilepsy in the rat brain. Neuroscience 65, 27-36 (1995).
38. Kirschstein, T. et al. The 27-kDa heat shock protein (HSP27) is a reliable hippocampal marker of full development of pilocarpine-induced status epilepticus. Epilepsy Res. 98, 35-43 (2012).
39. Calabrese, V. et al. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state. J. Neurochem. 101, 709-717 (2007).
40. Yang, T. T., Hsu, C. T. & Kuo, Y. M. Cell-derived soluble oligomers of human amyloid-beta peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons. J. Neural. Transm. 116, 1561-1569 (2009).
41. Waldbaum, S. & Patel, M. Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy. J. Bioenerg. Biomembr. 42, 449-455 (2010).
42. Willmore, L. J. & Ueda, Y. Posttraumatic epilepsy: hemorrhage, free radicals and the molecular regulation of glutamate. Neurochem. Res. 34, 688-697 (2009).
43. Sarangi, U. et al. Hsp60 chaperonin acts as barrier to pharmacologically induced oxidative stress mediated apoptosis in tumor cells with differential stress response. Drug Target Insights 7, 35-51 (2013).
44. Campanella, C. et al.Upon oxidative stress, the antiapoptotic Hsp60/procaspase-3 complex persists in mucoepidermoid carcinoma cells. Eur. J. Histochem. 524, 221-228 (2008).
45. Rowley, S. & Patel, M. Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic. Biol. Med. 62, 121-131 (2013).
46. Chandra, D., Choy, G. & Tang, D. G. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its proapoptotic or pro-survival functions involve differential interactions with caspase-3. J. Biol. Chem. 282, 31289-31301 (2007).
47. Feng, M. J., Zhang, L., Liu, Z., Zhou, P. & Lu, X. The expression and release of Hsp60 in 6 OHDA induced in vivo and in vitro models of Parkinson's disease. Neurochem Res. 38, 2180-2189 (2013).
48. Graner, M., W et al. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 23, 1541-1557 (2009).
49. Marchi, N. et al. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48, 732-742 (2007).
50. Marchi, N., Granata, T. &Janigro, D. Inflammatory pathways of seizure disorders. Trends Neurosci. 37, 55-65 (2014).
51. Van Vliet, E. A. et al. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130, 521-534 (2007).
52. Calabrese, V. et al. Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid Redox Signal. 8, 1975-1986 (2006).
53. Paxinos, G. & Watson, C. The rat brain in stereotaxic coordinates. Sydney: Academic Press; (1986).
54. Barone, R. et al. Endurance exercise and conjugated linoleic acid (CLA) supplementation up-regulate CYP17A1 and stimulate testosterone biosynthesis. PLoS One 8, e79686 (2013).
55. Quarato, P. P. et al. Temporal lobe epilepsy surgery: different surgical strategies after a non-invasive diagnostic protocol. J. Neurol. Neurosurg. Psychiatry 76, 815-824 (2005).